Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,065 | 2 | 118 | 452 | 32 |
| Receivables | 17 | 32 | 29 | 38 | 6 |
| TOTAL | $3,187 | $69 | $181 | $520 | $73 |
| Non-Current Assets | |||||
| PPE Net | 22 | 68 | 175 | 328 | 509 |
| Intangibles | 664 | 739 | 814 | 889 | 964 |
| Other Non-Current Assets | 474 | 590 | 22 | 22 | 34 |
| TOTAL | $1,160 | $1,398 | $1,011 | $1,239 | $1,507 |
| Total Assets | $4,347 | $1,466 | $1,192 | $1,759 | $1,580 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 119 | 1,954 | 1,894 | 2,455 | 2,284 |
| Accrued Expenses | 768 | 3,619 | 2,641 | 2,215 | 1,702 |
| Other current liabilities | N/A | 916 | 1,095 | 216 | N/A |
| TOTAL | $1,045 | $13,721 | $9,255 | $8,353 | $5,845 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,270 | N/A | 524 | 194 | 298 |
| Other Non-Current Liabilities | 364 | 522 | 55 | 48 | 438 |
| TOTAL | $4,634 | $522 | $579 | $242 | $735 |
| Total Liabilities | $5,679 | $14,243 | $9,833 | $8,595 | $6,580 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 953 | 905 | 4 | 2 | 2 |
| Common Shares | 0 | 8 | 1 | 6 | 5 |
| Retained earnings | -89,843 | -78,570 | -63,922 | -51,405 | -41,960 |
| TOTAL | $-1,332 | $-12,776 | $-8,641 | $-6,837 | $-5,000 |
| Total Liabilities And Equity | $4,347 | $1,466 | $1,192 | $1,759 | $1,580 |